People with pulmonary arterial hypertension and their physicians hardly ever agree on the severity of symptoms, a study shows ...
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pulmonary Arterial Hypertension (PAH) market will undergo major changes. According to the latest research, ...
The details of David Murphey’s cause of death have been revealed. The “90 Day’ fiancé” star passed away on Dec. 11 at 66 from ...
Patients with pulmonary arterial hypertension and cardiovascular comorbidities may benefit from the use of inhaled or oral ...
Flow Medical is developing a thrombolysis catheter that delivers TPA through hollow nitinol tubes to treat pulmonary embolism ...
Pulmonary hypertension (PH) is a chronic, life-threatening condition involving high blood pressure in the arteries of the ...
Stocktwits on MSN8d
Keros Stock Hits Rock Bottom After Pulmonary Hypertension Trial Halt, But Retail Bets On A ReboundKeros Therapeutics Inc. shares lost over three-quarters of their market capitalization on Thursday, marking an all-time low, ...
A recent systematic review assessed the psychometric properties of various instruments for measuring QOL in patients with ...
A pooled analysis of two prior trials suggests patients with a variety of cardiac index scores saw improvement when Winrevair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback